Xylo Technologies Ltd. (XYLO) - Total Liabilities
Based on the latest financial reports, Xylo Technologies Ltd. (XYLO) has total liabilities worth $19.96 Million USD as of December 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore XYLO year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Xylo Technologies Ltd. - Total Liabilities Trend (2016–2024)
This chart illustrates how Xylo Technologies Ltd.'s total liabilities have evolved over time, based on quarterly financial data.
Xylo Technologies Ltd. Competitors by Total Liabilities
The table below lists competitors of Xylo Technologies Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Iqstel Inc
NASDAQ:IQST
|
USA | $30.23 Million |
|
Intelligent Bio Solutions Inc.
NASDAQ:INBS
|
USA | $6.61 Million |
|
Ho Wah Genting Bhd
KLSE:9601
|
Malaysia | RM47.28 Million |
|
SIXTY SIX CAPITAL INC.
F:5CR0
|
Germany | €4.04 Million |
|
BlackRock Greater Europe Investment Trust plc
LSE:BRGE
|
UK | GBX30.48 Million |
|
EXPLOITS DISCOVERY CORP.
F:634
|
Germany | €320.26K |
|
Hub Cyber Security Ltd. Ordinary Shares
NASDAQ:HUBC
|
USA | $131.46 Million |
|
Ambipar Emergency Response
NYSE MKT:AMBI
|
USA | $4.29 Billion |
Liability Composition Analysis (2016–2024)
This chart breaks down Xylo Technologies Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see XYLO market cap.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.14 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.11 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.53 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Xylo Technologies Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Xylo Technologies Ltd. (2016–2024)
The table below shows the annual total liabilities of Xylo Technologies Ltd. from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $19.96 Million | -36.56% |
| 2023-12-31 | $31.46 Million | -26.77% |
| 2022-12-31 | $42.96 Million | +417.80% |
| 2021-12-31 | $8.30 Million | +35.11% |
| 2020-12-31 | $6.14 Million | +18.03% |
| 2019-12-31 | $5.20 Million | +64.65% |
| 2018-12-31 | $3.16 Million | +85.99% |
| 2017-12-31 | $1.70 Million | -5.37% |
| 2016-12-31 | $1.80 Million | -- |
About Xylo Technologies Ltd.
Xylo Technologies Ltd, a technology-based company, provides medical-related devices and products in the United States, Europe, Great Britain, Israel, Canada, Asia, and internationally. It operates through Corporate, Online Advertising & Internet Traffic Routing, Online Event Management, and Real-estate and Electronics segments. The company offers Medigus Ultrasonic Surgical Endostapler, an endosc… Read more